A study of women on long-term hormone replacement therapy and their attitude to suggested cessation

被引:12
作者
Horner, E. [1 ]
Fleming, J. [1 ]
Studd, J. [1 ]
机构
[1] Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London SW10 9NH, England
关键词
cessation of hormone replacement therapy; patients' attitudes and knowledge; women's health initiative; million women study; plasma estradioutestosterone levels; age;
D O I
10.1080/13697130601024629
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The study was undertaken to determine the effect of advice to discontinue hormone replacement therapy (HRT) on 100 women who were well established on treatment without side-effects. Method The study was retrospective from November 2003 to April 2004, in a single gynecological practice in London, UK. One hundred consecutive long-term estrogen and testosterone hormone implant users were assessed as to their knowledge of recent studies regarding risks of long-term HRT and whether they wished to discontinue hormones. Results All women receiving estrogen and testosterone implants, for a mean duration of 17.65 years (range 10-28 years), felt well informed concerning the Women's Health Initiative Study and the Million Women Study but only three women were happy to discontinue. The reasons given for the continuation of therapy were that they felt well and their quality of life had greatly improved. The mean estradiol and testosterone levels were 921 pmol/l and 1.91 nmol/l, respectively. Conclusions The high rate of continuation of hormone treatment indicates that, despite the recent adverse publicity, these women feel well informed and were not willing to discontinue with their hormone therapy if they felt well. A regular discussion of the risks and benefits of HRT remains mandatory.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 27 条
[1]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[2]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[3]  
Burger HG, 2002, FERTIL STERIL, V77, pS3
[4]   Androgens in women [J].
Davison, SL ;
Davis, SR .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) :363-366
[5]   Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort [J].
Fournier, A ;
Berrino, F ;
Riboli, E ;
Avenel, V ;
Clavel-Chapelon, F .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (03) :448-454
[6]   A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease [J].
Grodstein, F ;
Manson, JE ;
Colditz, GA ;
Willett, WC ;
Speizer, FE ;
Stampfer, MJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (12) :933-941
[7]   Attitude towards health and hormone replacement therapy among female obstetrician-gynecologists in Israel [J].
Kaplan, B ;
Yogev, Y ;
Sulkas, J ;
Geva, A ;
Nahum, R ;
Fisher, M .
MATURITAS, 2002, 43 (02) :113-116
[8]   Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis [J].
Khastgir, G ;
Studd, J ;
Holland, N ;
Alaghband-Zadeh, J ;
Sims, TJ ;
Bailey, AJ .
OSTEOPOROSIS INTERNATIONAL, 2001, 12 (06) :465-470
[9]   Estrogen plus progestin and the risk of coronary heart disease [J].
Manson, JE ;
Hsia, J ;
Johnson, KC ;
Rossouw, JE ;
Assaf, AR ;
Lasser, NL ;
Trevisan, M ;
Black, HR ;
Heckbert, SR ;
Detrano, R ;
Strickland, OL ;
Wong, ND ;
Crouse, JR ;
Stein, E ;
Cushman, M ;
Alving, B ;
Rossouw, JE ;
Pottern, L ;
Ludlam, S ;
McGowan, JA ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :523-534
[10]  
MONTGOMERY JC, 1987, LANCET, V1, P297